$VJET

Catheter Precision, now Flyte Aviation (VJET), completed a name change and 1-for-10 reverse stock split, reducing shares to 2.1M. The NYSE-listed company pivots to aviation, operating 5 jets and securing Bahamas/Caribbean approvals. Management aims to expand market share.

Flyte Aviation, Inc. (VTAK) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Flyte Aviation Launches Under NYSE American Ticker “ VJET ” ● Flyte Believes Its Proprietary Technology, Data, and Digital Booking Platform Can Disrupt the $11.6 Billion US Private Jet Charter Market ● Company believes its newly built AI-technology stack can fundamen

Catheter Precision, Inc. will change its NYSE American LLC stock ticker symbol from VTAK to VJET, effective October 5, 2026, according to an SEC filing.

Catheter repriced stock options for CEO David A. Jenkins and CFO Philip Anderson to $0.152 per share, adjusting to $1.52 due to a 1-for-10 reverse split. The changes, approved by stockholders, take effect on Sept 30, 2026, and Oct 5, 2026, respectively. Jenkins holds options for 89,999 shares, and Anderson for 66,315 shares, according to the company.

Catheter Precision, Inc. (VTAK) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 3.03 Material Modification to Rights of Security Holders. To the extent required by Item 3.03 of Form 8-K, the information set forth in Item 5.03 of this Current Report on Form 8-K is incorporated herein by reference. Item 5.02 Departure of Directors or Certain Officers; Ele

Catheter Precision (VTAK) will implement a 1-for-10 reverse stock split on October 5, 2026, reducing outstanding shares from 21.0 million to 2.1 million. The company will also change its name to Flyte Aviation and ticker to VJET. Ownership percentages remain unchanged except for fractional shares, which will be sold, and proportionate adjustments will be made to options, warrants, and convertible preferred stock. The stock will continue trading on the NYSE American.

Catheter Precision (NYSE American: VTAK) will change its name to Flyte Aviation and ticker to VJET on October 5, 2026. The company will also execute a 1-for-10 reverse stock split, reducing outstanding shares from 21.0 million to 2.1 million. The changes reflect the company's shift to private regional jet aviation.

Catheter Precision, Inc. (VTAK) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. On September 24, 2026, the Board of Directors (the “Board”) of Catheter Precision, Inc. (the “Company”) approved an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to (i) change the Company's name from “Catheter Pr

Catheter Precision Inc. (VTAK) is expanding its LockeT product commercialization across Latin America after a successful launch in Brazil. The company has partnered with a cardiology group to introduce LockeT in Argentina, Chile, and Colombia. LockeT is a suture retention device for wound closure, approved by the FDA and CE Mark. VTAK's stock is currently trading at $0.15, down 3.61%.

Catheter Precision, Inc. (VTAK) announced commercial milestones, including its first LockeT purchase order via Cardinal Health, which serves 90% of U.S. hospitals, and an order from Johns Hopkins. The company also placed its first VIVO 3D Imaging System in Germany, expanding its European presence. CEO David Jenkins highlighted the progress in distribution and clinical validation.